Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Term of the Day

Natural History Study

A natural history study is a preplanned intended to track the course of the disease. Its purpose is to identify demographic, genetic, environmental, and other variables (e.g., treatment modalities, concomitant medications) that correlate with the disease’s development and outcomes. Natural history studies are likely to include patients receiving the current standard of care and/or emergent care, which may alter some manifestations of the disease.

Population Pharmacokinetics

Pop PK, or Population Pharmacokinetics, refers to the study of the variability in drug concentrations among individuals in a target population, primarily due to differences in pharmacokinetic parameters. Pharmacokinetics (PK) itself is the study of how a drug is absorbed, distributed, metabolized, and excreted in the body over time.

In Pop PK:

  1. Variability is Quantified: The goal is to understand and quantify the sources of variability in drug response, which can arise from factors like age, weight, genetics, disease state, and concomitant medications.
  2. Modeling and Simulation: Pop PK uses mathematical models to describe the relationship between dose and plasma concentration in a population. These models can then be used to simulate drug concentrations under various dosing scenarios.
  3. Individualized Dosing: By understanding the variability in drug response, Pop PK can help in optimizing drug dosing for individual patients, ensuring that they receive the most effective dose with the least risk of adverse effects.
  4. Sparse Data: One advantage of Pop PK is that it can work with sparse data, meaning fewer blood samples per patient are needed compared to traditional PK studies. This is especially beneficial in populations where frequent sampling is challenging, such as neonates or critically ill patients.
  5. Covariate Analysis: Pop PK models often incorporate covariate analysis to determine how specific patient characteristics (e.g., age, renal function, genetic factors) influence pharmacokinetic parameters.